Pay attention to the animal drug market worth 3 trillion won
By Nho, Byung Chul | translator Kim, Jung-Ju
23.04.14 05:50:49
Yuhan Corp. expands sales of GedaCure, a treatment for canine cognitive dysfunction
Daewoong Pet Enterobiome develops microbiome-based companion animal food
Donghwa invests 5 billion won in Fitpet
Traditional pharmaceutical bio companies are entering the companion animal medicine and feed market worth 2.5 trillion won, attracting attention as they seek new growth engines and external expansion. Yuhan Corporation, Daewoong Pharmaceutical, Donghwa Pharmaceutical, Dongkuk Pharmaceutical, Kwangdong Pharmaceutical, Ildong Pharmaceutical, and CMG Pharmaceutical are among the companies that have declared their entry into the pet market and are taking active steps. These companies are expanding their brands by launching veterinary professional treatment and prescription animal medicines such as injections, antibiotics, and anthelmintics, as well as zoonotic medicines, nutritional supplements, and feed. For this reason
Nho, Byung Chul(sasiman@dailypharm.com)